Physitrack delivered a solid Q2, highlighted by margin expansion, positive free cash flow, and greater operational efficiency. Effects of the restructuring are now evident, with the company intensifying its focus on scalable, SaaS-led growth in the Wellness segment while keeping a tight grip on costs. Lifecare, which accounts for 78% of revenues, continued its steady performance, while growth in the smaller Wellness division (22% of revenues) remained muted, consistent with recent quarters. Outlook remains positive, and management sees room for further margin expansion ahead.

Läs mer på Redeye